Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Xiamen Yijiacheng Technology Co. Ltd. operates a patent portfolio in the Biotechnology & Pharmaceuticals technology area. The portfolio currently includes 1 pending office action. This prosecution is being conducted by 1 distinct examiner within 1 distinct art unit, representing a concentrated effort in this technology sector. The presence of 1 distinct art unit suggests that the technical arguments for the Biotechnology & Pharmaceuticals applications are being evaluated under the set of departmental standards for that unit.
The busiest examiner for the company is NGUYEN, NAM P, who has 1 busiest examiner pending action. This examiner is the sole individual managing the company's current pending workload. Prosecution strategy for Xiamen Yijiacheng Technology Co. Ltd. should be centered on the specific requirements of this 1 distinct examiner and the preferences of NGUYEN, NAM P. Since there is only 1 pending office action, the company must ensure its response is highly focused to move the portfolio forward through this administrative channel.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| NGUYEN, NAM P | 1 | 54.8% | +48.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18136377 | MICROSPHERE UNDERGOING DIVISIONAL FUNCTIONALIZATION MODIFICATION, AND APPLICATION THEREOF | NGUYEN, NAM P | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18136377 | MICROSPHERE UNDERGOING DIVISIONAL FUNCTIONALIZATION MODIFICATION, AND APPLICATION THEREOF | NGUYEN, NAM P | — |
| Art Unit | Apps |
|---|---|
| 1678 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18136377 | MICROSPHERE UNDERGOING DIVISIONAL FUNCTIONALIZATION MODIFICATION, AND APPLICATION THEREOF | NGUYEN, NAM P | 1678 | §103§112 | Non-Final OA | — | Pending | Apr 19, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialXiamen Yijiacheng Technology Co. Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Nam P Nguyen has the most, with 1 of Xiamen Yijiacheng Technology Co. Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
